Explora BioLabs Blog A2 Bio Achieves Success in Preclinical In Vivo Study with Explora's Preclinical Contract Research Services

A2 Bio creates powerful, precise T-cell therapies that attack solid tumors while sparing normal cells. This biotech is on the frontlines of cancer research, and when it needed a preclinical in vivo immuno-oncology study conducted, it turned to Explora BioLabs for its expertise, fast turnaround times, transparent communication, and all-around flexibility.